Pharma Mar, S.A. Profit Margin

Pharma Mar, S.A. (PHM.MC) currently reports a profit margin of 25.7% as of June 2026. That compares with 22.2% in the prior-year period — up 15.8% year over year. That is above the Healthcare sector average of 10.58%. Use the charts on this page to explore Pharma Mar, S.A.'s profit margin history and peer comparisons.

Pharma Mar, S.A.'s profit margin increased from 22.2% to 25.7% — a 15.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pharma Mar, S.A.'s profit margin of 25.7% is higher than the Healthcare sector average of 10.58%. That is roughly 142.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Pharma Mar, S.A.'s current 25.7% should be judged against Healthcare norms (sector average: 10.58%) and against PHM.MC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 25.7%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Pharma Mar, S.A., and consider following PHM.MC for alerts when major investors trade the stock.